Startup · $2.2m raised
Sydney, NSW
Every published round The University of Sydney took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Oli | Series A | 4 Aug 2026 | $6.5m | Participant | olimedical.com, Startup Daily (5 Aug 2026), SmartCompany, ontargetish.com, Startup Daily (26 May 2026), Forbes Australia, Dealroom | |
| Deteqt | Seed | 4 Aug 2026 | $5m | Participant | Startup Daily (5 Aug 2026), SmartCompany, Dealroom, Startup Daily (14 Apr 2026), Defence Connect, Forbes Australia, Beaten Zone Venture Partners, Beaten Zone Venture Partners portfolio, Main Sequence Ventures portfolio | |
| Regrow Ag | Accelerator | 2016 | - | Lead | Startup Daily (22 Jun 2023), Startup Daily (24 May 2022) |
Companies The University of Sydney has backed in a published round, and companies whose existing shares it bought off another holder.
Fund closes reported for The University of Sydney, as distinct from the investments it has made.
Companies The University of Sydney has backed that another company then bought. An exit for the holding, not a deal The University of Sydney did.
| Company | Bought by | Kind | Announced | Price |
|---|---|---|---|---|
| No portfolio company of The University of Sydney is recorded as having been acquired. | ||||
Companies The University of Sydney acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Every investor coverage indicates participated in a round The University of Sydney raised.
| Investor | Rounds | Invested |
|---|---|---|
| Australian Renewable Energy Agency | Grant | $2,200,000 |
| Defence | Grant | - |
| Name | Role | Sources |
|---|---|---|
| Prof Michael J. Biercuk | Quantum Physicist (former) | Startup Daily |
| Fergus (Gus) McLachlan | Senior Adviser for Defence and National Security | Defence Connect |
Stories naming The University of Sydney. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne dementia drug developer Kinoxis secured $6.75 million equity led by Main Sequence plus a $2.5 million Medical Research Future Fund grant via CUREator+, funding trials of its agitation and pain drug candidates.
Queensland feedlot cattle are being swabbed for BRD bacteria to support AgriCureX's phage and genomics research into antibiotic alternatives, a project MLA co-funds, with a first trial planned for mid-2027.
Sydney cleantech PlasmaLeap raised a US$20m Series A to build fertiliser hubs and expand green ammonia reactor technology for farmers.
Eight university- and company-led Australian quantum projects share $12.7 million in stage-two Critical Technologies Challenge Program grants, funding prototypes for data-centre cooling, medical imaging and rare-earth detection.
Sydney quantum software company Q-CTRL has launched free webinars teaching quantum computing basics, built on its Black Opal education platform, with more sessions planned across 2025.
DroneShield has appointed four seasoned national-security figures — van Haren, Osley, McLachlan and Lam-Evans — to strategy, advisory and government-relations roles as the counter-drone company scales.
Round 16 CRC-P grants, about $55 million across 23 projects, fund work involving CPC Engineering, ZiP Diagnostics, Emesent and Rux Energy across minerals processing, diagnostics, drone mapping and hydrogen storage.
SYNthesis BioVentures' third investor letter reports a roughly A$7.5m first close for Alzheimer's biotech S2N, lists co-investors, and profiles managing director Amir's career across OneVentures, Ceres Capital and other life-sciences roles.
Manufacturing sector roundup: Whyalla steelworks resumes production, Maggie Beer Holdings' chief executive to depart, ReNu Energy secures hydrogen funding, Defence names grant recipients, Orthocell gains Canadian approval, and AEA appoints its advisory board.
The Australian Renewable Energy Agency has expanded its hydrogen and green metals research funding to $59.1 million across 21 projects, with recipients including Hysata, Curtin University and Fortescue subsidiary MIH2.
CSIRO has picked twelve deep-tech teams, mostly from Australian universities, for the eighth edition of its ON Accelerate commercialisation program starting in February 2024.
Vaxxas reports positive Phase I results for its needle-free skin-patch delivery of a measles-rubella vaccine, with Gates Foundation grant funding and a planned PATH-sponsored Phase I/II trial in The Gambia.
Australian biotech OccuRx secured $16 million co-led by Brandon BioCatalyst and Uniseed, including a CUREator grant, to advance its oral anti-fibrosis therapy into kidney disease trials; two executives also joined.
Main Sequence announces Danielle Haj Moussa as a new part-time investment analyst, highlighting her mechatronics degree, University Medal, startup program experience and her co-founding of a tech-for-good community.